Global Leishmaniasis Treatment Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Leishmaniasis Treatment market will register a 5.2%% CAGR in terms of revenue, the global market size will reach $ 111.4 million by 2025, from $ 91 million in 2019. In particular, this report presents the global revenue market share of key companies in Leishmaniasis Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Leishmaniasis Treatment market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Leishmaniasis Treatment, covering the supply chain analysis, impact assessment to the Leishmaniasis Treatment market size growth rate in several scenarios, and the measures to be undertaken by Leishmaniasis Treatment companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Meglumine Antimoniate
Pentamidine
Hydroxyl Amidine Stilbene
Amphotericin B
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Visceral Leishmaniasis
Cutaneous Leishmaniasis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
iCo Therapeutics
AEterna Zentaris AG
Eurofins Advinus
AEterna Zentaris
Pieris Pharmaceuticals
Dafra Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Leishmaniasis Treatment market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Leishmaniasis Treatment market by identifying its various subsegments.
Focuses on the key global Leishmaniasis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Leishmaniasis Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Leishmaniasis Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Leishmaniasis Treatment Market Size 2015-2025
2.1.2 Leishmaniasis Treatment Market Size CAGR by Region
2.2 Leishmaniasis Treatment Segment by Type
2.2.1 Meglumine Antimoniate
2.2.2 Meglumine Antimoniate
2.2.3 Hydroxyl Amidine Stilbene
2.2.4 Amphotericin B
2.3 Leishmaniasis Treatment Market Size by Type
2.3.1 Global Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
2.3.2 Global Leishmaniasis Treatment Market Size Growth Rate by Type (2015-2020)
2.4 Leishmaniasis Treatment Segment by Application
2.4.1 Visceral Leishmaniasis
2.4.2 Cutaneous Leishmaniasis
2.5 Leishmaniasis Treatment Market Size by Application
2.5.1 Global Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
2.5.2 Global Leishmaniasis Treatment Market Size Growth Rate by Application (2015-2020)
3 Global Leishmaniasis Treatment by Players
3.1 Global Leishmaniasis Treatment Market Size Market Share by Players
3.1.1 Global Leishmaniasis Treatment Market Size by Players (2018-2020)
3.1.2 Global Leishmaniasis Treatment Market Size Market Share by Players (2018-2020)
3.2 Global Leishmaniasis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Leishmaniasis Treatment by Regions
4.1 Leishmaniasis Treatment Market Size by Regions
4.2 Americas Leishmaniasis Treatment Market Size Growth
4.3 APAC Leishmaniasis Treatment Market Size Growth
4.4 Europe Leishmaniasis Treatment Market Size Growth
4.5 Middle East & Africa Leishmaniasis Treatment Market Size Growth
5 Americas
5.1 Americas Leishmaniasis Treatment Market Size by Countries
5.2 Americas Leishmaniasis Treatment Market Size by Type
5.3 Americas Leishmaniasis Treatment Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Leishmaniasis Treatment Market Size by Regions
6.2 APAC Leishmaniasis Treatment Market Size by Type
6.3 APAC Leishmaniasis Treatment Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Leishmaniasis Treatment by Countries
7.2 Europe Leishmaniasis Treatment Market Size by Type
7.3 Europe Leishmaniasis Treatment Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Leishmaniasis Treatment by Countries
8.2 Middle East & Africa Leishmaniasis Treatment Market Size by Type
8.3 Middle East & Africa Leishmaniasis Treatment Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Leishmaniasis Treatment Market Forecast
10.1 Global Leishmaniasis Treatment Market Size Forecast (2021-2025)
10.2 Global Leishmaniasis Treatment Forecast by Regions
10.2.1 Global Leishmaniasis Treatment Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Leishmaniasis Treatment Forecast by Type
10.8 Global Leishmaniasis Treatment Forecast by Application
11 Key Players Analysis
11.1 Merck
11.1.1 Company Details
11.1.2 Leishmaniasis Treatment Product Offered
11.1.3 Merck Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Merck News
11.2 iCo Therapeutics
11.2.1 Company Details
11.2.2 Leishmaniasis Treatment Product Offered
11.2.3 iCo Therapeutics Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 iCo Therapeutics News
11.3 AEterna Zentaris AG
11.3.1 Company Details
11.3.2 Leishmaniasis Treatment Product Offered
11.3.3 AEterna Zentaris AG Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 AEterna Zentaris AG News
11.4 Eurofins Advinus
11.4.1 Company Details
11.4.2 Leishmaniasis Treatment Product Offered
11.4.3 Eurofins Advinus Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Eurofins Advinus News
11.5 AEterna Zentaris
11.5.1 Company Details
11.5.2 Leishmaniasis Treatment Product Offered
11.5.3 AEterna Zentaris Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 AEterna Zentaris News
11.6 Pieris Pharmaceuticals
11.6.1 Company Details
11.6.2 Leishmaniasis Treatment Product Offered
11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Pieris Pharmaceuticals News
11.7 Dafra Pharma
11.7.1 Company Details
11.7.2 Leishmaniasis Treatment Product Offered
11.7.3 Dafra Pharma Leishmaniasis Treatment Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Dafra Pharma News
...
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Leishmaniasis Treatment Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Meglumine Antimoniate
Table 5. Major Players of Pentamidine
Table 6. Major Players of Hydroxyl Amidine Stilbene
Table 7. Major Players of Amphotericin B
Table 8. Leishmaniasis Treatment Market Size by Type (2014-2019) ($ Millions)
Table 9. Global Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Table 10. Global Leishmaniasis Treatment Market Size by Application (2015-2020) ($ Millions)
Table 11. Global Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
Table 12. Global Leishmaniasis Treatment Revenue by Players (2018-2020) ($ Millions)
Table 13. Global Leishmaniasis Treatment Revenue Market Share by Players (2018-2020)
Table 14. Global Leishmaniasis Treatment Key Players Head office and Products Offered
Table 15. Leishmaniasis Treatment Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Leishmaniasis Treatment Market Size by Regions 2015-2020 ($ Millions)
Table 19. Global Leishmaniasis Treatment Market Size Market Share by Regions 2015-2020
Table 20. Americas Leishmaniasis Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 21. Americas Leishmaniasis Treatment Market Size Market Share by Countries (2015-2020)
Table 22. Americas Leishmaniasis Treatment Market Size by Type (2015-2020) ($ Millions)
Table 23. Americas Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Table 24. Americas Leishmaniasis Treatment Market Size by Application (2015-2020) ($ Millions)
Table 25. Americas Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
Table 26. APAC Leishmaniasis Treatment Market Size by Regions (2015-2020) ($ Millions)
Table 27. APAC Leishmaniasis Treatment Market Size Market Share by Regions (2015-2020)
Table 28. APAC Leishmaniasis Treatment Market Size by Type (2015-2020) ($ Millions)
Table 29. APAC Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Table 30. APAC Leishmaniasis Treatment Market Size by Application (2015-2020) ($ Millions)
Table 31. APAC Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
Table 32. Europe Leishmaniasis Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 33. Europe Leishmaniasis Treatment Market Size Market Share by Countries (2015-2020)
Table 34. Europe Leishmaniasis Treatment Market Size by Type (2015-2020) ($ Millions)
Table 35. Europe Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Table 36. Europe Leishmaniasis Treatment Market Size by Application (2015-2020) ($ Millions)
Table 37. Europe Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
Table 38. Middle East & Africa Leishmaniasis Treatment Market Size by Countries (2015-2020) ($ Millions)
Table 39. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Leishmaniasis Treatment Market Size by Type (2015-2020) ($ Millions)
Table 41. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Table 42. Middle East & Africa Leishmaniasis Treatment Market Size by Application (2015-2020) ($ Millions)
Table 43. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Application (2015-2020)
Table 44. Key and Potential Regions of Leishmaniasis Treatment
Table 45. Key Application and Potential Industries of Leishmaniasis Treatment
Table 46. Key Challenges of Leishmaniasis Treatment
Table 47. Key Trends of Leishmaniasis Treatment
Table 48. Global Leishmaniasis Treatment Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 49. Global Leishmaniasis Treatment Market Size Market Share Forecast by Regions
Table 50. Global Leishmaniasis Treatment Market Size Forecast by Type (2021-2025) ($ Millions)
Table 51. Global Leishmaniasis Treatment Market Size Market Share Forecast by Type (2021-2025)
Table 52. Global Leishmaniasis Treatment Market Size Forecast by Application (2021-2025) ($ Millions)
Table 53. Global Leishmaniasis Treatment Market Size Market Share Forecast by Application (2021-2025)
Table 54. Merck Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 55. Merck Leishmaniasis Treatment Product Offered
Table 56. Merck Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 57. Merck Main Business
Table 58. Merck Latest Developments
Table 59. iCo Therapeutics Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 60. iCo Therapeutics Leishmaniasis Treatment Product Offered
Table 61. iCo Therapeutics Main Business
Table 62. iCo Therapeutics Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 63. iCo Therapeutics Latest Developments
Table 64. AEterna Zentaris AG Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 65. AEterna Zentaris AG Leishmaniasis Treatment Product Offered
Table 66. AEterna Zentaris AG Main Business
Table 67. AEterna Zentaris AG Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 68. AEterna Zentaris AG Latest Developments
Table 69. Eurofins Advinus Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 70. Eurofins Advinus Leishmaniasis Treatment Product Offered
Table 71. Eurofins Advinus Main Business
Table 72. Eurofins Advinus Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 73. Eurofins Advinus Latest Developments
Table 74. AEterna Zentaris Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 75. AEterna Zentaris Leishmaniasis Treatment Product Offered
Table 76. AEterna Zentaris Main Business
Table 77. AEterna Zentaris Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 78. AEterna Zentaris Latest Developments
Table 79. Pieris Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 80. Pieris Pharmaceuticals Leishmaniasis Treatment Product Offered
Table 81. Pieris Pharmaceuticals Main Business
Table 82. Pieris Pharmaceuticals Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 83. Pieris Pharmaceuticals Latest Developments
Table 84. Dafra Pharma Details, Company Total Revenue (in $ million), Head Office, Leishmaniasis Treatment Major Market Areas and Its Competitors
Table 85. Dafra Pharma Leishmaniasis Treatment Product Offered
Table 86. Dafra Pharma Main Business
Table 87. Dafra Pharma Leishmaniasis Treatment Revenue and Gross Margin (2018-2020E)
Table 88. Dafra Pharma Latest Developments
List of Figures
Figure 1. Leishmaniasis Treatment Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Leishmaniasis Treatment Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Leishmaniasis Treatment Market Size Market Share by Type (2015-2020)
Figure 5. Global Meglumine Antimoniate Market Size Growth Rate
Figure 6. Global Pentamidine Market Size Growth Rate
Figure 7. Global Hydroxyl Amidine Stilbene Market Size Growth Rate
Figure 8. Global Amphotericin B Market Size Growth Rate
Figure 9. Leishmaniasis Treatment in Visceral Leishmaniasis
Figure 10. Global Leishmaniasis Treatment Market: Visceral Leishmaniasis (2015-2020) ($ Millions)
Figure 11. Leishmaniasis Treatment in Cutaneous Leishmaniasis
Figure 12. Global Leishmaniasis Treatment Market: Cutaneous Leishmaniasis (2015-2020) ($ Millions)
Figure 13. Global Leishmaniasis Treatment Market Size Market Share by Application in 2019
Figure 14. Global Leishmaniasis Treatment Market Size Market Share by Regions 2015-2020
Figure 15. Americas Leishmaniasis Treatment Market Size 2015-2020 ($ Millions)
Figure 16. APAC Leishmaniasis Treatment Market Size 2015-2020 ($ Millions)
Figure 17. Europe Leishmaniasis Treatment Market Size 2015-2020 ($ Millions)
Figure 18. Middle East & Africa Leishmaniasis Treatment Market Size 2015-2020 ($ Millions)
Figure 19. Americas Leishmaniasis Treatment Market Size Market Share by Countries in 2019
Figure 20. Americas Leishmaniasis Treatment Market Size Market Share by Type in 2019
Figure 21. Americas Leishmaniasis Treatment Market Size Market Share by Application in 2019
Figure 22. United States Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 23. Canada Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 24. Mexico Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 25. APAC Leishmaniasis Treatment Market Size Market Share by Regions in 2019
Figure 26. APAC Leishmaniasis Treatment Market Size Market Share by Type in 2019
Figure 27. APAC Leishmaniasis Treatment Market Size Market Share by Application in 2019
Figure 28. China Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 29. Japan Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 30. Korea Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 31. Southeast Asia Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 32. India Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 33. Australia Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 34. Europe Leishmaniasis Treatment Market Size Market Share by Countries in 2019
Figure 35. Europe Leishmaniasis Treatment Market Size Market Share by Type in 2019
Figure 36. Europe Leishmaniasis Treatment Market Size Market Share by Application in 2019
Figure 37. Germany Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 38. France Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 39. UK Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 40. Italy Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 41. Russia Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 42. Spain Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 43. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Countries in 2019
Figure 44. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Type in 2019
Figure 45. Middle East & Africa Leishmaniasis Treatment Market Size Market Share by Application in 2019
Figure 46. Egypt Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 47. South Africa Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 48. Israel Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 49. Turkey Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 50. GCC Countries Leishmaniasis Treatment Market Size Growth 2015-2020 ($ Millions)
Figure 51. Global Leishmaniasis Treatment arket Size Forecast (2021-2025) ($ Millions)
Figure 52. Americas Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 53. APAC Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 54. Europe Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 55. Middle East & Africa Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 56. United States Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 57. Canada Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 58. Mexico Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 59. Brazil Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 60. China Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 61. Japan Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 62. Korea Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 63. Southeast Asia Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 64. India Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 65. Australia Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 66. Germany Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 67. France Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 68. UK Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 69. Italy Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 70. Russia Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 71. Spain Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 72. Egypt Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 73. South Africa Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 74. Israel Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 75. Turkey Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)
Figure 76. GCC Countries Leishmaniasis Treatment Market Size 2021-2025 ($ Millions)